CanSino Biologics Inc

06185

Company Profile

  • Business description

    CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

  • Contact

    185 South Avenue
    401-420, 4th Floor, Biomedical Park
    TEDA West District
    Tianjin
    CHN

    T: +86 4009222099

    https://www.cansinotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,105

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,799.4029.30-0.33%
CAC 407,766.7143.240.56%
DAX 4024,206.91133.240.55%
Dow JONES (US)44,240.76165.60-0.37%
FTSE 1008,854.1847.650.54%
HKSE24,148.07260.241.09%
NASDAQ20,418.465.950.03%
Nikkei 22539,633.8354.98-0.14%
NZX 50 Index12,732.84126.18-0.98%
S&P 5006,225.524.46-0.07%
S&P/ASX 2008,562.6028.10-0.33%
SSE Composite Index3,496.970.51-0.01%

Market Movers